APAC Clinical Trials in COVID-19 Pandemic-Best Practices and Expectations for Continuity in Global Drug Development

This article talks about the best practices adopted by Covance APAC during COVID-19 pandemic - The path for recovery was not trivial - it required innovative problem solving and the coordinated efforts of cross-functional teams. Learn about the steps the Covance APAC teams took to: ensure continuity of drug development; set sponsors' expectations for trial readiness in APAC; and develop best practices for a recovery model, which could be implemented beyond APAC to support global trials in the US and EU.

Filed In

Phase IIb
Preclinical & Nonclinical
Stage (Early, PhI-IIa)
Stage (Late, PhIIb-III)
Stage (Post-Market, PhIV)